These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3356076)

  • 1. Pathomorphological changes in experimentally induced canine myocardial infarction.
    Tomaru T; Uchida Y; Sugimoto T
    Clin Cardiol; 1988 Mar; 11(3):149-57. PubMed ID: 3356076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effects of batroxobin on experimental canine coronary thrombosis.
    Tomaru T; Uchida Y; Sonoki H; Sugimoto T
    Clin Cardiol; 1988 Apr; 11(4):223-30. PubMed ID: 3163298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of myocardial hemorrhage after coronary reperfusion in the anesthetized dog.
    Higginson LA; White F; Heggtveit HA; Sanders TM; Bloor CM; Covell JW
    Circulation; 1982 Jan; 65(1):62-9. PubMed ID: 7053289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial infarction induced by coronary venous thrombosis--an experimental study.
    Miyahara K; Sakamoto H; Sakamoto H; Satoh E
    Jpn Circ J; 1990 Sep; 54(9):1165-73. PubMed ID: 2266578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological study of myocardial infarction with normal or nearly normal extracardiac coronary arteries. Quantitative analysis of contraction band necrosis, coagulation necrosis, hemorrhage, and infarct size.
    Wu DJ; Fujiwara H; Matsuda M; Ishida M; Kawamura A; Takemura G; Kida M; Uegaito T; Fujiwara T; Kawai C
    Heart Vessels; 1990; 6(1):55-62. PubMed ID: 2289910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intermittent coronary sinus occlusion on experimental myocardial infarction and reperfusion hemorrhage.
    Ikeoka K; Nakagawa Y; Kawashima S; Fujitani K; Iwasaki T
    Jpn Circ J; 1990 Oct; 54(10):1258-73. PubMed ID: 2126046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional myocardial salvage by coadministration of the epoprostenol analog taprostene to recombinant single-chain urokinase-type plasminogen activator in a canine coronary thrombosis model.
    Groves R; Schneider J; Friderichs E; Giertz H; Flohé L
    Arzneimittelforschung; 1989 Apr; 39(4):534-8. PubMed ID: 2665759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of residual coronary stenosis on size of infarction after reperfusion in a canine preparation.
    Schmidt SB; Varghese PJ; Bloom S; Yackee JM; Ross AM
    Circulation; 1986 Jun; 73(6):1354-9. PubMed ID: 3698261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced myocardial salvage by maintenance of microvascular patency following initial thrombolysis with recombinant tissue plasminogen activator.
    Longridge DJ; Follenfant MJ; Maxwell MP; Ford AJ; Hughes B
    Cardiovasc Res; 1990 Sep; 24(9):697-706. PubMed ID: 2121357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.
    Jun L; Arnout J; Vanhove P; Dol F; Lormeau JC; Herbert JM; Collen D; Van de Werf F
    Coron Artery Dis; 1995 Mar; 6(3):257-63. PubMed ID: 7788040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of contraction band and coagulation necrosis after ischemia and reperfusion in the porcine heart.
    Miyazaki S; Fujiwara H; Onodera T; Kihara Y; Matsuda M; Wu DJ; Nakamura Y; Kumada T; Sasayama S; Kawai C
    Circulation; 1987 May; 75(5):1074-82. PubMed ID: 3568307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single bolus administration of recombinant tissue plasminogen activator: effects on infarct related vessel patency, microvascular perfusion, and microvascular reocclusion in a canine model of thrombotic occlusion/reperfusion.
    Longridge DJ; Follenfant MJ; Ford AJ
    Cardiovasc Res; 1991 Mar; 25(3):184-91. PubMed ID: 1903080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraction band necrosis: its modification by the free radical scavenger N-2-mercaptopropionyl glycine.
    Widman SC; Liang CS; Schenk EA; Hood WB
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):694-701. PubMed ID: 7532745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
    Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
    Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the thrombolytic efficacy of defibrase and urokinase on canine coronary artery thrombosis and the mechanism of urokinase-induced hemorrhage.
    Huang DX; Song A; Yang X; Wang S
    Acta Cardiol; 1987; 42(4):249-61. PubMed ID: 3499037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
    Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
    Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental study on the comparative thrombolytic effects of intracoronary and intravenous administration of urokinase.
    Tomoda H
    Jpn Heart J; 1986 Mar; 27(2):259-65. PubMed ID: 3723801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of reperfusion on myocardial infarct, and the accuracy of estimating infarct size from serum creatine phosphokinase in the dog.
    Jarmakani JM; Limbird L; Graham TC; Marks RA
    Cardiovasc Res; 1976 Mar; 10(2):245-53. PubMed ID: 938992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of infarct size, contraction band necrosis, and coagulation necrosis in human autopsied hearts with acute myocardial infarction after treatment with selective intracoronary thrombolysis.
    Matsuda M; Fujiwara H; Onodera T; Tanaka M; Wu DJ; Fujiwara T; Hamashima Y; Kawai C
    Circulation; 1987 Nov; 76(5):981-9. PubMed ID: 3665003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage.
    Kloner RA; Ellis SG; Lange R; Braunwald E
    Circulation; 1983 Aug; 68(2 Pt 2):I8-15. PubMed ID: 6861331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.